| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8454817 | Lung Cancer | 2015 | 6 Pages |
Abstract
Our data showed that de novo MET expression was not rare. It was not a predictive or prognostic factor for stage IV NSCLC patients, but this should be confirmed in larger population cohort.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Anna Li, Fei-Yu Niu, Jie-Fei Han, Na-Na Lou, Jin-Ji Yang, Xu-Chao Zhang, Qing Zhou, Zhi Xie, Jian Su, Ning Zhao, Ying Huang, Yi-Long Wu,